170 related articles for article (PubMed ID: 20006707)
1. Non-viral nanosystems for systemic siRNA delivery.
David S; Pitard B; Benoît JP; Passirani C
Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
[TBL] [Abstract][Full Text] [Related]
2. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
3. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.
Zhi D; Zhao Y; Cui S; Chen H; Zhang S
Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
5. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting in the silent era: advances in non-viral siRNA delivery.
Guo J; Fisher KA; Darcy R; Cryan JF; O'Driscoll C
Mol Biosyst; 2010 Jul; 6(7):1143-61. PubMed ID: 20431817
[TBL] [Abstract][Full Text] [Related]
8. Supramolecular assemblies in functional siRNA delivery: where do we stand?
Aliabadi HM; Landry B; Sun C; Tang T; Uludağ H
Biomaterials; 2012 Mar; 33(8):2546-69. PubMed ID: 22209641
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
Kumari A; Kumar V; Yadav SK
Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
[TBL] [Abstract][Full Text] [Related]
10. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
Akhtar S
Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
[TBL] [Abstract][Full Text] [Related]
11. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
[TBL] [Abstract][Full Text] [Related]
12. Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.
Zhou Y; Zhang C; Liang W
J Control Release; 2014 Nov; 193():270-81. PubMed ID: 24816071
[TBL] [Abstract][Full Text] [Related]
13. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
Meade BR; Dowdy SF
Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of siRNA delivery by nanoparticles.
Yuan X; Naguib S; Wu Z
Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
[TBL] [Abstract][Full Text] [Related]
15. Efficient and targeted delivery of siRNA in vivo.
Shim MS; Kwon YJ
FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
[TBL] [Abstract][Full Text] [Related]
16. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
17. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
[TBL] [Abstract][Full Text] [Related]
18. [Current status of non-viral vectors for siRNA delivery].
Yang FF; Huang W; Li YF; Gao ZG
Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
[TBL] [Abstract][Full Text] [Related]
19. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
20. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
